These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39398547)

  • 1. Comparison of efficacy and safety between loading-dose atorvastatin and rosuvastatin in cerebral infarction.
    Li Y; Zhang D; Liu S; Ni W; Wang C; Yu B; Guan J; Shao J; Zhang Q
    Am J Transl Res; 2024; 16(9):4633-4642. PubMed ID: 39398547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
    Adel EM; Elberry AA; Abdel Aziz A; Naguib IA; Alghamdi BS; Hussein RRS
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36079090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
    Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of low-dose rosuvastatin with atorvastatin in lipid-lowering efficacy and safety in a high-risk pakistani cohort: an open-label randomized trial.
    Arshad AR
    J Lipids; 2014; 2014():875907. PubMed ID: 24800084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Study Between the Effects of High Doses of Rosuvastatin and Atorvastatin on Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction.
    Elhadad ZM; Kassem AB; Amrawy AME; Salahuddin A; El-Bassiouny NA
    Cardiovasc Drugs Ther; 2024 Sep; ():. PubMed ID: 39264503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
    Lee YJ; Hong SJ; Kang WC; Hong BK; Lee JY; Lee JB; Cho HJ; Yoon J; Lee SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK;
    BMJ; 2023 Oct; 383():e075837. PubMed ID: 37852649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations.
    Zhang L; Zhang S; Yu Y; Jiang H; Ge J
    Herz; 2020 Sep; 45(6):594-602. PubMed ID: 30483816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of High-Intensity Statins in the Veteran Population: Atorvastatin 40 to 80 mg Compared With Rosuvastatin 20 to 40 mg.
    Stein B; Ward T; Hale G; Lyver E
    Ann Pharmacother; 2020 May; 54(5):405-413. PubMed ID: 31718234
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study.
    Kilit C; Koçak FE; Paşalı Kilit T
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):235-243. PubMed ID: 28429691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel-group, multicenter study (DISCOVERY Alpha study).
    Binbrek AS; Elis A; Al-Zaibag M; Eha J; Keber I; Cuevas AM; Mukherjee S; Miller TR;
    Curr Ther Res Clin Exp; 2006 Jan; 67(1):21-43. PubMed ID: 24936119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study.
    Godino C; Pavon AG; Mangieri A; Salerno A; Cera M; Monello A; Chieffo A; Magni V; Cappelletti A; Margonato A; Colombo A
    Clin Cardiol; 2017 Aug; 40(8):605-611. PubMed ID: 28422300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
    Hu X; Cheng J; Li C
    Eur J Clin Pharmacol; 2018 Jan; 74(1):29-35. PubMed ID: 28965256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
    Toso A; Leoncini M; Maioli M; Tropeano F; Villani S; Bellandi F
    Cardiorenal Med; 2020; 10(5):288-301. PubMed ID: 32434204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerivastatin for lowering lipids.
    Adams SP; Tiellet N; Alaeiilkhchi N; Wright JM
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012501. PubMed ID: 31981471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy comparison of rosuvastatin and atorvastatin in the treatment of atherosclerosis and drug safety analysis.
    Liping Z; Xiufang L; Tao Y; Baomin Z; Houshuai T
    Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2203-2208. PubMed ID: 30463813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.